3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase 2
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Carcinoma, Hepatocellular
3
Sarcoma, Ewing
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia, Biphenotypic, Acute
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Interventions
pembrolizumab
31
Nivolumab
15
Paclitaxel
13
Carboplatin
13
Cyclophosphamide
12
sacituzumab govitecan
8
Cisplatin
8
Capecitabine
7
130-nm albumin-bound paclitaxel
7
Gemcitabine
6
fludarabine
5
durvalumab
5
avelumab
5
atezolizumab
5
Magnetic Resonance Spectroscopy
5
Ipilimumab
5
Biopsy
5
camrelizumab
4
Specimen Handling
4
Interleukin-2
4
Injections
4
Immune Checkpoint Inhibitors
4
Docetaxel
4
toripalimab
3
talazoparib
3
Leucovorin
3
Immunoglobulin G
3
Everolimus
3
Clinical Trials, Phase II as Topic
3
Bevacizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Triple Negative Breast Neoplasms
×
X-Rays
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled